Success Stories: EB-1A Approved for Staff Clinician in Maryland in the Field of Oncology
Client’s Testimonial:
Thank you for the great news! Indeed I found your firm prompt, efficient, responsive, and very good at what you do. I am happy to and will certainly refer friends.
On May 20th, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Staff Clinician in the Field of Oncology (Approval Notice)
Position at the Time of Case Filing: Staff Clinician
Country of Origin: India
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Maryland
Approval Notice Date: May 20th, 2015
Processing Time: 29 days (13 days after premium processing was requested)
In this case, the client that we had the opportunity to work with was a Staff Clinician from India in the field of Oncology. He had conducted his research in the highly specialized area of developing treatments for thoracic cancers, such as thymic cancer, lung cancer, and mesothelioma, and other types of hematological cancer such as leukemia and multiple myeloma. His work had resulted in 42 peer-reviewed scientific articles and numerous presentations at national and international conferences; at the time that his case was filed, his publications had been cited at least 402 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also reviewed 7 manuscripts for distinctive, internationally-circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “Overall, [Client] is a clinical oncology researcher of the highest caliber. His published work enjoys the attention of fellow leading researchers at institutions across the globe.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Oncology, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 29 days.